SNC
CLB icon

Stifel Nicolaus & Co’s Core Laboratories CLB Stock Holding History

Stifel Nicolaus & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.09M Buy
6,466
+199
+3% +$30.9K 0.02% 638
2013
Q2 		$950K Buy
+6,267
New +$888K 0.02% 646

Other funds holding CLB

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Stifel Nicolaus & Co's CLB Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Core Laboratories (CLB) stake by 3.2% in Q3 2013, buying an estimated $30.9K and bringing the position to 6,466 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #638.

Stifel Nicolaus & Co first reported a position in CLB in Q2 2013 and has held it in 2 quarters since. 302 funds tracked by Wall St. Rank hold CLB as of Q3 2013.

  • Stifel Nicolaus & Co held 6,466 shares of Core Laboratories worth $1.09M as of Q3 2013.
  • Stifel Nicolaus & Co bought 199 Core Laboratories shares in Q3 2013, an estimated $30.9K.
  • Core Laboratories made up 0.02% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #638 holding.
  • Stifel Nicolaus & Co first reported a position in Core Laboratories in Q2 2013 and has held it in 2 quarters since.
  • 302 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.